HighTower Advisors’s Replimune Group REPL Stock Holding History

HighTower Advisors’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,123	Closed	-$196K	–	3912
2025 Q4	$196K	Buy	20,123 +3,994	+25%	+$34K	﹤0.01%	3388
2025 Q3	$67.6K	Buy	+16,129	New	+$103K	﹤0.01%	3588

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighTower Advisors's REPL Position: Q1 2026 in Review

HighTower Advisors sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 20,123 shares — an estimated $196K sold.

HighTower Advisors first reported a position in REPL in Q3 2025 and held it in 2 quarters. The position peaked at $196K in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

HighTower Advisors reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
HighTower Advisors sold 20,123 Replimune Group shares in Q1 2026, an estimated $196K.
HighTower Advisors first reported a position in Replimune Group in Q3 2025 and held it in 2 quarters.
HighTower Advisors's Replimune Group position peaked at $196K in Q4 2025.
180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.